{"summary":"Tian is an immunologist by training with a passion for drug development and commercialization. She is detail-oriented and strong in execution. She has 10 years of research experience in academia and industry combined.","lastName":"Sun, PhD","objectUrn":"urn:li:member:204339357","geoRegion":"Toronto, Ontario, Canada","fullName":"Tian Sun, PhD","firstName":"Tian","currentPositions":[{"companyName":"ImmunoBiochem Corporation","description":"Advancing the development of novel tumor microenvironment-targeted antibody-drug conjugates (ADCs) for the treatment of heterogeneous solid tumors.\n- Leading preclinical and MOA studies to better understand the wider applicability of the company's lead oncology assets\n- Creating comprehensive data packages (target validation, proof-of-concept, xenograft studies, PD and PK) for a new immunomodulating ADC asset\n- Building data room and presentation decks to facilitate collaboration and due diligence\n- Supporting business development efforts through competitive landscape analysis \n- Cultivating and maintaining strong relationships with academic collaborators and industrial partners to facilitate research projects","title":"Research Scientist","companyUrnResolutionResult":{"employeeCountRange":"2-10","headquarters":{"geographicArea":"Ontario","country":"Canada","city":"Toronto","postalCode":"M5G 0B7","line2":"13102H","line1":"661 Uiversity Avenue, Suite 1300"},"website":"https:\/\/www.immunobiochem.com","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/immunobiochem\/","industry":"Biotechnology Research"},"companyUrn":"urn:li:fs_salesCompany:5335691","tenureAtCompany":{"numYears":5,"numMonths":5},"startedOn":{"year":2019}}],"entityUrn":"urn:li:fs_salesProfile:(ACwAAAwt-J0BZ0gR1vetYeDIJBZvXsiCnAbFqZ0,NAME_SEARCH,Jq2u)","profilePictureDisplayImage":{"artifacts":[{"width":100,"fileIdentifyingUrlPathSegment":"100_100\/0\/1700966516965?e=1723075200&v=beta&t=9KXAnMOLuULyMq4t74TVeF_FfgSjWzjQB8foa4VMHcE","height":100},{"width":200,"fileIdentifyingUrlPathSegment":"200_200\/0\/1700966516965?e=1723075200&v=beta&t=EtbmQoLvzM1NJlwlVBvT8gRmIeFDu7weYKO-ImsuN8I","height":200},{"width":400,"fileIdentifyingUrlPathSegment":"400_400\/0\/1700966516965?e=1723075200&v=beta&t=A3RxHgxrBTr3HyvAF4vU3sebnYZJBll25XK6ckvIYkk","height":400},{"width":800,"fileIdentifyingUrlPathSegment":"800_800\/0\/1700966516965?e=1723075200&v=beta&t=AYWtKs8rNtVZRh4JKCttGxUzxnFDZLV80wxubte_UG0","height":800}],"rootUrl":"https:\/\/media.licdn.com\/dms\/image\/D5603AQG3PJNruRYzJA\/profile-displayphoto-shrink_"},"projects":[],"contactInfo":{},"industry":"Biotechnology Research","educations":[{"endedOn":{"year":2017},"degree":"Doctor of Philosophy - PhD","eduId":124952804,"schoolUrn":"urn:li:fs_salesSchool:3660","school":"urn:li:fs_salesSchool:3660","fieldsOfStudy":["Immunology"],"schoolName":"University of Toronto","startedOn":{"year":2012}},{"endedOn":{"year":2019},"eduId":582561388,"schoolUrn":"urn:li:fs_salesSchool:846328","school":"urn:li:fs_salesSchool:846328","fieldsOfStudy":["GMP and GLP"],"schoolName":"University of Toronto School of Continuing Studies","startedOn":{"year":2019}},{"endedOn":{"year":2012},"degree":"Bachelor's Degree","eduId":148808740,"schoolUrn":"urn:li:fs_salesSchool:289531","school":"urn:li:fs_salesSchool:289531","fieldsOfStudy":["Biology\/Biological Sciences, General"],"schoolName":"Nanjing University","startedOn":{"year":2008}}],"skills":[{"numOfEndorsement":0,"name":"Mammalian Cell Culture"},{"numOfEndorsement":0,"name":"Oral Communication"},{"numOfEndorsement":0,"name":"Presentations"},{"numOfEndorsement":0,"name":"Standard Operating Procedure (SOP)"},{"numOfEndorsement":0,"name":"Multi-color Flow Cytometry"},{"numOfEndorsement":0,"name":"Life Sciences"},{"numOfEndorsement":0,"name":"Good Laboratory Practice (GLP)"},{"numOfEndorsement":1,"name":"Problem Solving"},{"numOfEndorsement":1,"name":"Pre-clinical Studies"},{"numOfEndorsement":1,"name":"Attention to Detail"},{"numOfEndorsement":0,"name":"Biology"},{"numOfEndorsement":5,"name":"Flow Cytometry"},{"numOfEndorsement":4,"name":"Data Analysis"},{"numOfEndorsement":10,"name":"Immunology"},{"numOfEndorsement":6,"name":"Research"},{"numOfEndorsement":4,"name":"ELISA"},{"numOfEndorsement":3,"name":"PCR"},{"numOfEndorsement":2,"name":"Genetics"},{"numOfEndorsement":2,"name":"Scientific Writing"},{"numOfEndorsement":1,"name":"qPCR"},{"numOfEndorsement":1,"name":"Cell Biology"},{"numOfEndorsement":1,"name":"Statistics"},{"numOfEndorsement":0,"name":"Animal Models"},{"numOfEndorsement":0,"name":"Biotechnology"},{"numOfEndorsement":2,"name":"Project Management"},{"numOfEndorsement":0,"name":"Immunohistochemistry"},{"numOfEndorsement":11,"name":"Cell Culture"},{"numOfEndorsement":0,"name":"Microsoft Office"},{"numOfEndorsement":0,"name":"Adobe Illustrator"},{"numOfEndorsement":0,"name":"Adobe Photoshop"},{"numOfEndorsement":0,"name":"EndNote"},{"numOfEndorsement":0,"name":"FlowJo"},{"numOfEndorsement":0,"name":"GraphPad Prism"},{"numOfEndorsement":0,"name":"Scientific Presentation"},{"numOfEndorsement":0,"name":"Scientific Communications"},{"numOfEndorsement":9,"name":"Molecular Biology"},{"numOfEndorsement":0,"name":"Data Visualization"},{"numOfEndorsement":0,"name":"R"},{"numOfEndorsement":0,"name":"Python (Programming Language)"},{"numOfEndorsement":0,"name":"Perl"},{"numOfEndorsement":2,"name":"Polymerase Chain Reaction (PCR)"}],"numOfConnections":860,"patents":[],"headline":"Immuno-oncology Scientist | Content Creator","courses":[],"certifications":[{"companyUrn":"urn:li:fs_salesCompany:3526187","url":"https:\/\/www.coursera.org\/account\/accomplishments\/verify\/W2ZJGCV3K83B","authority":"Coursera Course Certificates","name":"Data Management for Clinical Research","company":"urn:li:fs_salesCompany:3526187","licenseNumber":"W2ZJGCV3K83B","startedOn":{"month":8,"year":2018}},{"authority":"Mitacs","name":"Foundations of Project Management I&II","company":"urn:li:fs_salesCompany:118745","startedOn":{"month":6,"year":2018},"companyUrn":"urn:li:fs_salesCompany:118745"},{"authority":"Coursera","name":"Machine Learning","company":"urn:li:fs_salesCompany:2453129","startedOn":{"month":5,"year":2019},"companyUrn":"urn:li:fs_salesCompany:2453129"},{"companyUrn":"urn:li:fs_salesCompany:162977","url":"http:\/\/basno.com\/wpvzlbn1","authority":"CFA Institute","name":"Investment foundations","company":"urn:li:fs_salesCompany:162977","startedOn":{"month":4,"year":2020}}],"memberBadges":{"premium":false,"openLink":false,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/immtiansun","organizations":[{"endedOn":{"month":8,"year":2015},"name":"Chinese Students and Scholars Association (CSSA)","position":"Academia Rep","startedOn":{"month":9,"year":2014}},{"endedOn":{"month":8,"year":2015},"name":"Immunology Graduate Students Association (IGSA)","position":"Community Outreach Rep","startedOn":{"month":9,"year":2014}},{"endedOn":{"month":12,"year":2016},"name":"The American Association of Immunologists (AAI)","description":"- Presented orally and a poster at AAI 2016 meeting in Seattle","position":"Trainee member","startedOn":{"month":1,"year":2016}},{"endedOn":{"month":12,"year":2014},"name":"Canadian Society for Immunology (CSI)","description":"- Presented a poster at CSI 2014 meeting in Quebec city","position":"Trainee member","startedOn":{"month":1,"year":2014}},{"endedOn":{"month":12,"year":2016},"name":"Society for Mucosal Immunology (SMI)","description":"- Presented posters and orally during two meetings: 2015 International Congress of Mucosal Immunology (ICMI) in Berlin and 2016 Mucosal Immunology Course and Symposium (MICS) in Toronto","position":"Trainee member","startedOn":{"month":1,"year":2015}},{"endedOn":{"month":12,"year":2017},"name":"The Federation of Clinical Immunology Societies (FOCIS)","description":"- Presented a poster at the FOCIS 2017 meeting in Chicago","position":"Trainee member","startedOn":{"month":1,"year":2017}},{"name":"Canadian and Chinese Biomedical and Pharmaceutical Association","startedOn":{"month":1,"year":2017}}],"location":"Toronto, Ontario, Canada","publications":[{"publishedOn":{"month":7,"year":2016},"description":"Sun T, Rojas OL, Li C, et al.\nThe requirement of a specific dendritic cell subset is different between adult and neonatal mice, in shaping the adaptive antiviral immune responses at the intestinal mucosa.","url":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27600308","name":"Intestinal Batf3-dependent Dendritic Cells are required for Optimal Antiviral T-cell Responses in Adult and Neonatal Mice","publisher":"Mucosal Immunology","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAwt-J0BZ0gR1vetYeDIJBZvXsiCnAbFqZ0,NAME_SEARCH,Jq2u)"}]},{"publishedOn":{"month":12,"year":2015},"description":"Sun T, Rojas OL, Li C, et al.\nExploring whether dendritic cell-intrinsic lymphotoxin \u03b2 receptor signaling is required for the host defence to intestinal viral infections.","url":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26657790","name":"Hematopoietic LT\u03b2R deficiency results in skewed T cell cytokine profiles during a mucosal viral infection","publisher":"Journal of Leukocyte Biology","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAwt-J0BZ0gR1vetYeDIJBZvXsiCnAbFqZ0,NAME_SEARCH,Jq2u)"}]},{"publishedOn":{"month":1,"year":2015},"description":"Motta V, Soares F, Sun T, et al.\nDescription of NLR genes associated with different biological processes and the molecular mechanisms underlying their functions and related human diseases.","url":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25540141","name":"NOD-like receptors: versatile cytosolic sentinels","publisher":"Physiological Reviews","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAwt-J0BZ0gR1vetYeDIJBZvXsiCnAbFqZ0,NAME_SEARCH,Jq2u)"}]},{"publishedOn":{"month":7,"year":2012},"description":"Guo X, Li X, Xu Y, Sun T, et al.\nCharacterization of OASL d as a novel isoform of human OASL that possesses antiviral activity against RNA viruses","url":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22531715","name":"Identification of OASL d, a splice variant of human OASL, with antiviral activity","publisher":"International Journal of Biochemistry and Cell Biology","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAwt-J0BZ0gR1vetYeDIJBZvXsiCnAbFqZ0,NAME_SEARCH,Jq2u)"}]},{"publishedOn":{"month":1,"year":2019},"description":"Rojas OL, Pr\u00f6bstel AK, Porfilio EA, Wang AA, Charabati M, Sun T, et al.\nThe small intestine is the major source of immune regulatory cells that mitigate brain inflammation in patients with multiple sclerosis.","url":"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30612739","name":"Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10","publisher":"Cell","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAwt-J0BZ0gR1vetYeDIJBZvXsiCnAbFqZ0,NAME_SEARCH,Jq2u)"}]},{"publishedOn":{"month":2,"year":2019},"description":"Sun T, Ferrero RL, Girardin SE, et al.\nNlrc5 deficiency results in impaired H2-K-restricted antigen-specific CD8+ T cell responses, which is recapitulated in mice deficient of Nlrc5 within the dendritic cell compartment","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/30768806\/","name":"NLRC5 deficiency has a moderate impact on immunodominant CD8+ T cell responses during rotavirus infection of adult mice","publisher":"Immunology & Cell Biology","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAwt-J0BZ0gR1vetYeDIJBZvXsiCnAbFqZ0,NAME_SEARCH,Jq2u)"}]},{"publishedOn":{"month":12,"day":20,"year":2019},"description":"We investigated when during mouse immune system development signals initiated by lymphotoxin expression are needed to enable an effective mucosal IgA antibody response after rotavirus infection of adult mice.","url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31862865\/","name":"Early Life Programming of Mesenteric Lymph Node Stromal Cell Identity by the Lymphotoxin Pathway Regulates Mucosal Immune Responses in the Adult","publisher":"Science Immunology","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAwt-J0BZ0gR1vetYeDIJBZvXsiCnAbFqZ0,NAME_SEARCH,Jq2u)"}]},{"publishedOn":{"month":3,"day":1,"year":2020},"description":"Sun T, Nguyen A, Gommerman JL\nInvited review about dendritic cell subsets in the intestinal immunity","url":"https:\/\/www.jimmunol.org\/content\/204\/5\/1075","name":"Dendritic Cell Subsets in Intestinal Immunity and Inflammation","publisher":"Journal of Immunology","authors":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAAAwt-J0BZ0gR1vetYeDIJBZvXsiCnAbFqZ0,NAME_SEARCH,Jq2u)"}]}],"positions":null,"posts":[{"createdAt":1710411360000,"insightId":"2dab5a21-9dac-44d4-8cca-3dd147154235","activityUnion":{"postActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":26},{"type":"PRAISE","count":6}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:ugcPost:7173985422681780224","threadUrn":"urn:li:ugcPost:7173985422681780224","reactionsCount":32,"commentsCount":2,"canComment":true},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7173985422681780224","message":{"attributes":[{"length":12,"start":16,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:14776151"}}}],"text":"Great news from Tubulis GmbH! The completion of the Series B2 financing round will give us the opportunity to support not only the clinical evaluation of our lead ADC candidates TUB-030 and TUB-040, but also to further expand our pipeline. Happy to be part of the team and to share their vision of delivering the true value of ADCs!"},"rootActivity":{"contentSummaryUnion":{"mediaContentSummary":{"title":{"text":"Series B2"},"mediaType":"PAGINATEDDOCUMENT"}},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:ugcPost:7173981383390904320","message":{"attributes":[{"start":139,"length":10,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:financing"}}},{"start":161,"length":17,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:79163517"}}},{"start":184,"length":14,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:1209545"}}},{"start":245,"length":21,"value":{"com.linkedin.common.CompanyAttributedEntity":{"company":"urn:li:company:78826620"}}},{"start":520,"length":4,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:adc"}}},{"start":693,"length":11,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:solidtumor"}}},{"start":956,"length":15,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:845275730"}}},{"start":978,"length":16,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:13283147"}}},{"start":1130,"length":8,"value":{"com.linkedin.common.HashtagAttributedEntity":{"hashtag":"urn:li:hashtag:cancers"}}},{"start":1164,"length":22,"value":{"com.linkedin.common.HyperlinkAttributedEntity":{"url":"https:\/\/bit.ly\/3IxICOZ"}}}],"text":"Today marks a pivotal moment in the evolution of Tubulis. We have successfully closed an upsized and oversubscribed \u20ac128 million Series B2 #financing co-led by \u200bEQT Life Sciences\u200b and Nextech Invest, with participation from new US-based funds, \u200bFrazier Life Sciences\u200b and Deep Track Capital, as well as all of our existing investors.\n\nThe support of this syndicate of leading global biotech investors underscores the potential of our unique approach to pioneering the next wave of truly differentiated, disease-specific #ADC therapeutics. With this funding, we are well-positioned to advance our next-generation ADCs into clinical evaluation and achieve clinical proof-of-concept for our lead #SolidTumor candidates, TUB-040 and TUB-030. The proceeds will also support the further development of our technology platforms to unlock novel payloads and the establishment of a US subsidiary to expand our corporate footprint.\n\nWe look forward to working with \u200bChristoph Broja\u200b and \u200bKanishka Pothula\u200b as new members of our Supervisory Board to realize our vision of providing new, high-quality treatment options for many hard-to-treat #cancers.\n\nRead the full PR here: https:\/\/bit.ly\/3IxICOZ\n"},"entityUrn":"urn:li:ugcPost:7173981383390904320"},"entityUrn":"urn:li:ugcPost:7173985422681780224"}}}]}